Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +55.72%
#3 Ontology Gas Ontology Gas +36.94%
#4 DogBull DogBull +36.89%
#5 BOOK OF MEME BOOK OF MEME +30.55%
#6 Neiro Neiro +21.85%
#7 Collect on Fanable Collect on Fanable +21.43%
#8 Nockchain Nockchain +19.56%
#9 Pump.fun Pump.fun +19.14%
#10 Unit Pump Unit Pump +19.14%
Coin of the day
Pleasing Gold Pleasing Gold
Setări
Limbă
ROMâNă
Monedă
USD
Temă
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Rang în acțiuni #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Preț acțiune
$0.12164306
Ultima sincronizare: 2024-11-11
Capitalizare de piață
$38.53M
Schimbare (1 zi)
-4.14%
Schimbare (1 an)
0.00%
Țară
AU
Tranzacționează PharmAust Limited (PAA)

Categorie

Healthcare
Venituri pentru PharmAust Limited (PAA)
Venituri în Jun 2024 TTM: $572.45K
Conform celor mai recente rapoarte financiare ale PharmAust Limited, venitul actual al companiei (TTM) este $572.45K. În anul 2023, compania a avut un venit de $1.88M o scădere comparativ cu venitul din anul 2022, care a fost de $2.33M. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru PharmAust Limited din 2001 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
2026 (TTM) $572.45K 0.00%
2024 0.00 -100.00%
2023 $1.88M -19.32%
2022 $2.33M 45.33%
2021 $1.60M -27.22%
2020 $2.21M -27.76%
2019 $3.05M 26.47%
2018 $2.41M -5.23%
2017 $2.55M 25.80%
2016 $2.02M 10.90%
2015 $1.83M -0.20%
2014 $1.83M 17.05%
2013 $1.56M -5.48%
2012 $1.65M -0.67%
2011 $1.66M 19.79%
2010 $1.39M -2.17%
2009 $1.42M -47.01%
2008 $2.68M -55.73%
2007 $6.05M 33.53%
2006 $4.53M 85.63%
2005 $2.44M 1,047.74%
2004 $212.83K 366.98%
2003 $45.58K -88.07%
2002 $381.98K 0.00%
2001 0.00 0.00%
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 2,205,224.96%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 1,051,752.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B 2,741,683.32%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 389,106.85%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH